Publicado 6 números por año
ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472
Indexed in
Immune Responses Against Persistent Viral Infections: Possible Avenues for Immunotherapeutic Interventions
SINOPSIS
Persistent viral infections present a significant threat to society, and treatment options for infected individuals are in urgent demand. During viral persistence, the balance between the virus and the host immune response is crucial. The immune system keeps the virus in check, and the virus counters by evading the immune response to avoid clearance, ultimately tipping the balance in favor of the virus and causing disease in many cases. Thus, efforts to tip the balance in favor of the host through immunotherapy holds promise for establishing control of viral replication. However, in most persistent viral infections, the continuous presence of the viral antigen renders virus-specific T cells to become dysfunctional. These differences can range from severe functional impairments in high-load persistent infections, to more subtle changes in infections with a lower virus burden. Recent work has shed light on immunoregulatory molecules or cytokines that affect viral persistence and/or T-cell function, and interventions that modulate these factors have led to effective viral control in experimental models. Exploitation of these experimental therapies may lead to treatments that would be of great clinical benefit to patients suffering from persistent virus infections, such as HIV, HBV, or HCV, or the herpesviruses CMV and EBV.
-
Ersche Karen D., Hagan Cindy C., Smith Dana G., Abbott Sanja, Jones P. Simon, Apergis-Schoute Annemieke M., Döffinger Rainer, Aberrant Disgust Responses and Immune Reactivity in Cocaine-Dependent Men, Biological Psychiatry, 75, 2, 2014. Crossref
-
Alter Galit, Kavanagh Daniel, Rihn Suzannah, Luteijn Rutger, Brooks David, Oldstone Michael, van Lunzen Jan, Altfeld Marcus, IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection, Journal of Clinical Investigation, 120, 6, 2010. Crossref
-
Knuschke Torben, Bayer Wibke, Rotan Olga, Sokolova Viktoriya, Wadwa Munisch, Kirschning Carsten J., Hansen Wiebke, Dittmer Ulf, Epple Matthias, Buer Jan, Westendorf Astrid M., Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection, Nanomedicine: Nanotechnology, Biology and Medicine, 10, 8, 2014. Crossref
-
Sauer Arnaud, Villard Odile, Creuzot-Garcher Catherine, Chiquet Christophe, Berrod Jean-Paul, Speeg-Schatz Claude, Bourcier Tristan, Candolfi Ermanno, Papasian C. J., Intraocular Levels of Interleukin 17A (IL-17A) and IL-10 as Respective Determinant Markers of Toxoplasmosis and Viral Uveitis, Clinical and Vaccine Immunology, 22, 1, 2015. Crossref
-
Jovel Juan, Schneemann Anette, Molecular characterization of Drosophila cells persistently infected with Flock House virus, Virology, 419, 1, 2011. Crossref
-
Wilson Cara C., Schooley Robert T., Host Responses to Infection, in Infectious Diseases, 2017. Crossref
-
Perkins Molly R., Ryschkewitsch Caroline, Liebner Julia C., Monaco Maria Chiara G., Himelfarb Danielle, Ireland Sara, Roque Annelys, Edward Heather L., Jensen Peter N., Remington Gina, Abraham Thomas, Abraham Jaspreet, Greenberg Benjamin, Kaufman Charles, LaGanke Chris, Monson Nancy L., Xu Xiaoning, Frohman Elliot, Major Eugene O., Douek Daniel C., Imperiale Michael J., Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy, PLoS Pathogens, 8, 11, 2012. Crossref
-
Bradley Jillian H., Stein Rachel, Randolph Brad, Molina Emily, Arnold Jennifer P., Gregg Randal K., T cell resistance to activation by dendritic cells requires long-term culture in simulated microgravity, Life Sciences in Space Research, 15, 2017. Crossref
-
Nali Luiz Henrique da Silva, Moraes Lenira, Fink Maria Cristina Domingues, Callegaro Dagoberto, Romano Camila Malta, Oliveira Augusto Cesar Penalva de, Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients, Arquivos de Neuro-Psiquiatria, 72, 12, 2014. Crossref
-
Blaney Joseph E., Marzi Andrea, Willet Mallory, Papaneri Amy B., Wirblich Christoph, Feldmann Friederike, Holbrook Michael, Jahrling Peter, Feldmann Heinz, Schnell Matthias J., Schmaljohn Connie S., Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine, PLoS Pathogens, 9, 5, 2013. Crossref
-
Zickovich Julianne M., Meyer Susan I., Yagita Hideo, Obar Joshua J., Lenz Laurel L., Agonistic Anti-CD40 Enhances the CD8+ T Cell Response during Vesicular Stomatitis Virus Infection, PLoS ONE, 9, 8, 2014. Crossref
-
Molloy Michael J., Zhang Weijun, Usherwood Edward J., Suppressive CD8+ T Cells Arise in the Absence of CD4 Help and Compromise Control of Persistent Virus, The Journal of Immunology, 186, 11, 2011. Crossref
-
Wang Li, Li Na, Fan Xiude, Wang Xiaoyun, Zhang Xiaoge, Zhang Kun, Han Qunying, Lv Yi, Liu Zhengwen, Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic hepatitis B virus infection, International Immunopharmacology, 82, 2020. Crossref
-
Tahir ul Qamar Muhammad, Shokat Zeeshan, Muneer Iqra, Ashfaq Usman Ali, Javed Hamna, Anwar Farooq, Bari Amna, Zahid Barira, Saari Nazamid, Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach, Vaccines, 8, 2, 2020. Crossref
-
Macatangay Bernard J. C., Zheng Lu, Rinaldo Charles R., Landay Alan L., Pollard Richard B., Pahwa Savita, Lederman Michael M., Bucy R. Pat, Comparison of Immunologic Assays for Detecting Immune Responses in HIV Immunotherapeutic Studies: AIDS Clinical Trials Group Trial A5181, Clinical and Vaccine Immunology, 17, 9, 2010. Crossref
-
Schooley Robert, Wilson Cara, Host responses to infection, in Infectious Diseases, 2010. Crossref
-
Tahir ul Qamar Muhammad, Rehman Abdur, Tusleem Kishver, Ashfaq Usman Ali, Qasim Muhammad, Zhu Xitong, Fatima Israr, Shahid Farah, Chen Ling-Ling, Barozai Muhammad Younas Khan, Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches, PLOS ONE, 15, 12, 2020. Crossref
-
Guedes Marta Catarina Esteves, Martins Catarina Gregório, Arroz Maria Jorge, Angelo-Dias Miguel, Borrego Luís Miguel, Proença Rui Daniel, Cytokine profiles in the peripheral blood and aqueous humor of patients with herpetic uveitis, Journal of Ophthalmic Inflammation and Infection, 10, 1, 2020. Crossref
-
Pyasi Shruti, Sharma Vinita, Dipti Kumari, Jonniya Nisha Amarnath, Nayak Debasis, Immunoinformatics Approach to Design Multi-Epitope- Subunit Vaccine against Bovine Ephemeral Fever Disease, Vaccines, 9, 8, 2021. Crossref
-
Li Wei, Han Jun, Wu Hong, Regulatory T‐cells promote hepatitis B virus infection and hepatocellular carcinoma progression, Chronic Diseases and Translational Medicine, 2, 2, 2016. Crossref
-
Han Shaobo, Asoyan Ayuna, Rabenstein Hannah, Nakano Naoko, Obst Reinhard, Role of antigen persistence and dose for CD4 + T-cell exhaustion and recovery , Proceedings of the National Academy of Sciences, 107, 47, 2010. Crossref
-
Hwang Ji Young, Sun Yanbo, Carroll Christopher R., Usherwood Edward J., D'Orazio Sarah E. F., Neuropilin-1 Regulates the Secondary CD8 T Cell Response to Virus Infection, mSphere, 4, 3, 2019. Crossref
-
Dowall Stuart D., Kempster Sarah, Findlay-Wilson Stephen, Mattiuzzo Giada, Graham Victoria A., Page Mark, Hewson Roger, Almond Neil, Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig model, Vaccine, 38, 2, 2020. Crossref
-
Zhang Weijun, Zhang Tong, Turk Mary-Jo, Usherwood Edward J., A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector, Cancer Immunology, Immunotherapy, 59, 5, 2010. Crossref